Newgreen Supply High Quality Trametes Robiniophila Extract Ear Polysaccharide Powder
Product Description:
Trametes Robiniophila is one of the important medicinal fungi in China. Its chemical constituents mainly contain polysaccharides, steroids and alkaloids. Trametes Robiniophila has been widely used in the adjuvant therapy of breast cancer, liver cancer, lung cancer, gastric cancer and other malignant tumors. Its mechanism of action includes inhibiting the growth and proliferation of tumor cells, invasion and metastasis, angiogenesis, inducing apoptosis of tumor cells, and improving immunity.
COA:
Product Name: |
Ear Polysaccharide |
Test Date: |
2024-06-19 |
Batch No.: |
NG24061801 |
Manufacture Date: |
2024-06-18 |
Quantity: |
2500kg |
Expiration Date: |
2026-06-17 |
ITEMS | STANDARD | RESULTS |
Appearance | Brown Powder | Conform |
Odor | Characteristic | Conform |
Taste | Characteristic | Conform |
Assay | ≥30.0% | 30.6% |
Ash Content | ≤0.2% | 0.15% |
Heavy Metals | ≤10ppm | Conform |
As | ≤0.2ppm | <0.2 ppm |
Pb | ≤0.2ppm | <0.2 ppm |
Cd | ≤0.1ppm | <0.1 ppm |
Hg | ≤0.1ppm | <0.1 ppm |
Total Plate Count | ≤1,000 CFU/g | <150 CFU/g |
Mold & Yeast | ≤50 CFU/g | <10 CFU/g |
E. Coll | ≤10 MPN/g | <10 MPN/g |
Salmonella | Negative | Not Detected |
Staphylococcus Aureus | Negative | Not Detected |
Conclusion | Conform to the specification of the requirement. | |
Storage | Store in a cool, dry and ventilated place place. | |
Shelf Life | Two years if sealed and store away from direct sun light and moisture. |
Function:
Modern pharmacological studies have shown that Trametes Robiniophila/Sophora auriculata can exert anti-tumor effects by inhibiting the growth and proliferation of tumor cells, inducing apoptosis of tumor cells, inhibiting angiogenesis, inhibiting the invasion and metastasis of tumor cells, regulating the expression of various oncogenes and tumor suppressor genes, improving the body immunity, reversing the drug resistance of tumor cells and so on. Its single flavor drugs and extracts as cancer adjuvant drugs were approved in China in 1997 for the treatment of primary liver cancer.
Application:
Trametes Robiniophila has certain anti-tumor effects on breast cancer, lung cancer, stomach cancer, liver cancer, prostate cancer, pancreatic cancer, kidney cancer, acute lymphoblastic leukemia and nodular sclerosis, and its targets are numerous, covering multiple pathways of tumor occurrence and development. In clinical practice, Trametes Robiniophila has therapeutic effect on various malignant tumors with little toxicity, which can delay the progression of tumor patients, improve the quality of life and prolong the survival of patients, and has a good application prospect.